ArticleJournal of medicinal chemistry2025

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis.

Eda Canales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.